Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Review of Emotion Regulation in Late Life Mood Disorders.
Patrick RE, Dickinson RA, Gregg A, Kaufman JR, Maciarz J, Merrill JG, Williams LA, Weisenbach SL. Patrick RE, et al. Among authors: merrill jg. J Psychiatr Brain Sci. 2024;9(6):e240008. doi: 10.20900/jpbs.20240008. Epub 2024 Nov 22. J Psychiatr Brain Sci. 2024. PMID: 39687283 Free PMC article.
Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Treatment Era.
Ma J, Delaney JAC, Ruderman SA, Nance RM, Hahn AW, Drumright LN, Whitney BM, Fredericksen RJ, Mixson LS, Merrill JO, Safren SA, Mayer KH, O'Cleirigh C, Napravnik S, Chander G, Moore RD, Christopoulos KA, Willig AL, Bamford L, Webel A, McCaul ME, Cachay ER, Jacobson JM, Saag MS, Kitahata MM, Crane HM, Williams EC. Ma J, et al. Among authors: merrill jo. AIDS Behav. 2024 Dec 3. doi: 10.1007/s10461-024-04566-x. Online ahead of print. AIDS Behav. 2024. PMID: 39625560 No abstract available.
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial.
Askanase AD, D'Cruz D, Kalunian K, Merrill JT, Navarra SV, Cahuzac C, Cornelisse P, Murphy MJ, Strasser DS, Trokan L, Berkani O. Askanase AD, et al. Among authors: merrill jt. Lancet Rheumatol. 2025 Jan;7(1):e21-e32. doi: 10.1016/S2665-9913(24)00246-7. Epub 2024 Nov 22. Lancet Rheumatol. 2025. PMID: 39586304 Clinical Trial.
1,630 results